Can-SCIP Coach App
  1. Can-SCIP
  2. Recommendations
  3. Guidelines
  4. Section 2 - MANAGEMENT OF SCI COMPLICATIONS

O - EMOTIONAL WELL-BEING




Screen all individuals with SCI for major depression by using a brief, valid measure that has good sensitivity and specificity:

  1. early during the initial inpatient hospital or rehabilitation stay
  2. as a repeat screen if indicated to assess persistence of symptoms or change in status
  3. at the first discharge follow-up point
  4. at least annually or more frequently, depending on risk stratification factors such as prior positive screening results and chronic pain.
(PVA-EWB 2020, p.161; Level C)
Refer patients with positive screen results or those suspected of having a depressive disorder to a mental health provider for diagnostic assessment and treatment. (Adapted from PVA-EWB 2020, p.161; Level C)
Follow up on positive screening test results by using a valid diagnostic assessment to confirm conditions such as major depressive disorder or adjustment disorder (including sufficient persistence of symptoms and interference with rehabilitation or role functioning) and rule out the possibility that the symptoms are better explained by the effects of the medical condition, medications, drugs, the environment, or other factors. (PVA-EWB 2020, p.161; Level C)
Follow up on positive screening test results by using a valid diagnostic assessment to confirm conditions such as major depressive disorder or adjustment disorder (including sufficient persistence of symptoms and interference with rehabilitation or role functioning) and rule out the possibility that the symptoms are better explained by the effects of the medical condition, medications, drugs, the environment, or other factors. (PVA-EWB 2020, p.161; Level C)
Treat major depression by using pharmacological and/or nonpharmacological approaches on the basis of clinical presentation (e.g., comorbid conditions), treatment efficacy, and patient preferences. (PVA-EWB 2020, p.161; Level A)
Consider pharmacological treatments for major depression. (PVA-EWB 2020, p.161; Level A)
Consider nonpharmacological treatments for major depression. (PVA-EWB 2020, p.161; Level A)
Clinicians should consider prescribing cognitive behavioural therapy as a treatment option for individuals with SCI and caregivers to reduce depressive symptoms. (CAN-SCIP 2020; Level A)